| Literature DB >> 35096655 |
Kevin D Mlynek1, Christopher T Lopez1, David P Fetterer2, Janice A Williams3, Joel A Bozue1.
Abstract
Biofilms have been established as an important lifestyle for bacteria in nature as these structured communities often enable survivability and persistence in a multitude of environments. Francisella tularensis is a facultative intracellular Gram-negative bacterium found throughout much of the northern hemisphere. However, biofilm formation remains understudied and poorly understood in F. tularensis as non-substantial biofilms are typically observed in vitro by the clinically relevant subspecies F. tularensis subsp. tularensis and F. tularensis subsp. holarctica (Type A and B, respectively). Herein, we report conditions under which robust biofilm development was observed in a stochastic, but reproducible manner in Type A and B isolates. The frequency at which biofilm was observed increased temporally and appeared switch-like as progeny from the initial biofilm quickly formed biofilm in a predictable manner regardless of time or propagation with fresh media. The Type B isolates used for this study were found to more readily switch on biofilm formation than Type A isolates. Additionally, pH was found to function as an environmental checkpoint for biofilm initiation independently of the heritable cellular switch. Multiple colony morphologies were observed in biofilm positive cultures leading to the identification of a particular subset of grey variants that constitutively produce biofilm. Further, we found that constitutive biofilm forming isolates delay the onset of a viable non-culturable state. In this study, we demonstrate that a robust biofilm can be developed by clinically relevant F. tularensis isolates, provide a mechanism for biofilm initiation and examine the potential role of biofilm formation.Entities:
Keywords: Francisella tularensis; biofilm; pH effect; phase variation; stochastic; viable non-culturable
Mesh:
Substances:
Year: 2022 PMID: 35096655 PMCID: PMC8795689 DOI: 10.3389/fcimb.2021.808550
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Bacterial strains used in this study.
| Strain Designation | Strain characteristics | Source/Reference |
|---|---|---|
| LVS | Vaccine strain (Type B) | USAMRIID Repository |
| FRAN244 | Schu S4 (Type A1) | BEI Resources (NR-10492) ( |
| FRAN249 | 1958 USAMRIID Schu S4 (Type A1) | BRMR1 ( |
| FRAN250 | (Type A1a) | BRMR ( |
| FRAN251 | (Type A1a) | BRMR ( |
| FRAN253 | (Type A1a) | BRMR ( |
| FRAN254 | (Type A1a) | BRMR ( |
| FRAN256 | Type A2 | BRMR ( |
| FRAN031 | Scherm (Type A1) | BRMR ( |
| FRAN037 | COLL (Type A1) | BRMR ( |
| FRAN255 | Type B | BRMR ( |
| FRAN025 | VT68 (Type B) | BRMR ( |
| FRAN029 | 425 (Type B) | BRMR ( |
| FRAN045 | 503 (Type B) | BRMR ( |
| LVS BF+ pop 25 | Heterogeneous population of LVS cultured that forms biofilm | Derived by culturing LVS for 7 days in CDM and selected by crystal violet staining. |
| LVS isolate #9 | BV selected from BF+ pop 25, | Derived from LVS during this study. |
| LVS isolate #10 | BV selected from BF+ pop 25, | Derived from LVS during this study. |
| LVS isolate #11 | GV selected from BF+ pop 25, | Derived from LVS during this study. |
| LVS isolate #12 | BV selected from BF+ pop 25 | Derived from LVS during this study. |
| LVS isolate #13 | GV selected from BF+ pop 25, | Derived from LVS during this study. |
| LVS isolate #14 | GV selected from BF+ pop 25, | Derived from LVS during this study. |
| LVS isolate #15 | GV selected from BF+ pop 25, | Derived from LVS during this study. |
| LVS isolate #16 | GV selected from BF+ pop 25, | Derived from LVS during this study. |
| LVS isolate #22 | GV selected from LVS based on biofilm formation | Derived from LVS during this study. |
| LVS isolate #26 | GV selected from LVS based on biofilm formation | Derived from LVS during this study. |
| LVS isolate #27 | GV selected from LVS based on biofilm formation | Derived from LVS during this study. |
| LVS isolate #31 | GV selected from LVS based on biofilm formation | Derived from LVS during this study. |
| LVS isolate #38 | GV selected from LVS based on biofilm formation | Derived from LVS during this study. |
| FRAN244 BF+ 1 | GV selected from FRAN244 based on biofilm formation | Derived from FRAN244 during this study. |
| FRAN255 BF+ 1 | GV selected from FRAN255 based on biofilm formation | Derived from FRAN255 during this study. |
| FRAN255 BF+ 4 | GV selected from FRAN255 based on biofilm formation | Derived from FRAN255 during this study. |
1Biodefense Reference Material Repository.
Figure 1F. tularensis subsp. holarctica LVS forms biofilm in a stochastic manner that is reproducible in progeny cells. (A) Biofilm formation in the original 96 well plates was assessed by crystal violet staining at the indicated time post inoculation. Prior to staining, the original plates were sub-cultured by replicate plating to create progeny plates. Progeny were assayed for biofilm development at 24 h post inoculation. Biofilm was quantitated by determining the OD600 values after crystal violet staining for the (B) original plates and (C) progeny plates. Each point graphed represents an individual well in an experiment. The percent displayed above the graph for each day indicates the percent of biofilm positive wells as described in the materials and methods. The red bar indicates the median value after at least 3 independent experiments. To assess stochastic biofilm formation the log transformed OD600 was analyzed by repeated measures linear mixed effects model. ***P < 0.0001.
Figure 3Stochastic biofilm formation is conserved across a diverse panel of fully virulent F. Tularensis type A and B isolates. (A) The ability of each isolate was assessed using crystal violet staining after 7 days of culturing in CDM in fully virulent Type A (white background) and B (grey background) isolates. LVS was included as a positive control in each assay. (B) Replicate plates were inoculated from the original 7 day plates of FRAN244 and FRAN255 (Type A and B isolates, respectively) to assess biofilm formation in progeny cells. Biofilm development was assayed at 24 h post inoculation. Each point graphed represents an individual well in an experiment. The red bar indicates the median value after at least 3 independent experiments.
Figure 4pH of the culture medium impacts the ability of F. tularensis to form biofilm. (A) LVS biofilm formation was assessed in Chamberlain’s defined medium (CDM), brain-heart infusion broth (BHI) supplemented with 1% IsoVitaleX and modified Mueller-Hinton broth (MMH) supplemented with 2% IsoVitaleX. Biofilms were assayed at 10 days post-inoculation. (B) LVS grown in either CDM or BHI for 7 days was sub-cultured via replica plating into CDM or BHI. (C) LVS biofilm formation was assessed after culturing for 7 days in CDM or BHI pH adjusted to 6.2 or 7. (D) The effect of culture medium pH was assessed in fully virulent Type A and B isolates (FRAN 244 and FRAN255, respectively). The red bar indicates the median value after at least 3 independent experiments. **P < 0.01.
Figure 6An inherent cell associated trait is responsible for biofilm formation in F. tularensis. (A) LVS was cultured for 7 days in CDM after which the contents of a biofilm negative and biofilm positive wells were separated into sterilized supernatant or repeatedly washed cells. The sterilized supernatant was applied to naïve cells and the ability to form biofilm was compared to washed cells only using crystal violet staining. The biofilm capacity of the (B) washed cells or (C) frozen biofilm positive stocks was assayed at 1, 3 and 5 days post-inoculation. Black bars indicates the median. *P < 0.05; **P < 0.01.
Figure 2Scanning electron microscopy shows a well-defined extracellular matrix in biofilm positive samples. (A) The biofilm of LVS biofilm was sampled at 1, 3, 5 and 7 days and analyzed by SEM. The blue and red rectangle (day 5 and 7, respectively) highlight the enlarged area. Grey arrows labeled progeny indicate the original samples from which cells were sub-cultured to obtain progeny micrographs. Teal arrow indicates surface depositions. Green arrow indicates a smooth, totally encased biofilm. Purple arrow indicates a string-like extracellular matrix. Golden arrow indicates cell to cell projections. (B) Representative images of the range of biofilm formation observed in a 7 day culture of LVS. Yellow asterisk (top panel) indicates the area that is enlarged (bottom panel). Images displayed are representative from multiple independent experiments.
Figure 5pH acts as an environmental checkpoint for initiation of biofilm matrix assembly. LVS biofilms were grown in CDM adjusted to the indicated pH. After 7 days, bacteria were sub-cultured into either CDM at pH 6.2 or 7 and the progeny biofilms were stained at 24 h. (A) Representative images of biofilm plates crossed into CDM at each pH. (B) Graphed data after 3 independent experiments. Red bars indicates the median. OG indicates the original plates from which progeny plates were inoculated.
Figure 7Blue-grey phase variation is readily observed in biofilm forming cultures. (A) Western blot analysis of LVS strains was performed on 8 representative colony variants that arose after streaking biofilm positive freezer stocks on chocolate agar. Pellets from purified isolates were lysed and equal concentrations of extracts were separated on SDS-PAGE gels blotted with either α-LPS (left) or α-capsule (right). In each case, α-GroEL was used as a loading control. WT corresponds to the wild-type LVS strain. Numbers correspond to the respective variant isolates. (B) A crystal violet biofilm assay was used to determine the biofilm forming capacity of each of the purified LVS isolates. Red asterisks indicate grey variants as identified by western blotting. Red lines indicate the median.
Figure 8Grey variants are responsible for the production of biofilm in F. tularensis. (A) Biofilm formation of purified constitutive biofilm forming isolates assayed by crystal violet staining after 3 days of growth in CDM. Grey shaded area highlights fully virulent Type A and B F. tularensis isolates and the isogenic biofilm former. (B) Western blot analysis was performed on the purified biofilm forming isolates to assess LPS and capsule. Bacteria were suspended to an equal OD600. Cell pellets were lysed and were separated on SDS-PAGE gels blotted with either α-LPS (left) or α-capsule (right). Equal amounts of whole cell extracts were loaded, with the exception of 244 and 255 as these isolates were diluted 1:4 and 1:2, respectively. In each case, α-GroEL was used as a loading control.
Figure 9Biofilm forming isolates delay the onset of a viable, but non-culturable state. (A) F. tularensis LVS (grey), a biofilm forming population (black) and a purified constitutive biofilm forming isolate (white) derived from wild-type LVS were streaked onto chocolate agar and incubated at 37°C. At the time indicated, CDM was inoculated and incubated shaking at 37°C for 24 h. The OD600 was obtained as a measurement of bacterial growth. Samples were diluted as required to maintain the linear range of measurement. Graphed data show the average of at least 3 independent experiments with the standard error of the mean. (B) An aliquot of the bacteria present from the 24h broth culture was assayed for viability using Live/DEAD stain followed by fluorescent microscopy. In these representative images, bacteria with an intact membrane (live) stain green while those with an impaired membrane (dead) are indicated by red staining. LVS exposed to 70% EtOH for 15 minutes was stained and imaged alongside samples to serve as a control.